|
Volumn 96, Issue 2, 2001, Pages 136-142
|
ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection
a a a |
Author keywords
Delayed cardioprotection; ERK; Opioid; p38; Preconditioning
|
Indexed keywords
1,2,3,4,4A,5,12,12AALPHA OCTAHYDRO 4AALPHA (3 HYDROXYPHENYL) 2 METHYLQUINOLINO[2,3 G]ISOQUINOLINE;
2 (2 AMINO 3 METHOXYPHENYL)CHROMONE;
4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE;
MITOGEN ACTIVATED PROTEIN KINASE;
OPIATE;
SYNAPTOPHYSIN;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
DRUG INHIBITION;
ENZYME ACTIVATION;
ENZYME PHOSPHORYLATION;
HEART INFARCTION PREVENTION;
HEART INFARCTION SIZE;
HEART MUSCLE ISCHEMIA;
HEART MUSCLE REPERFUSION;
HEART PROTECTION;
MALE;
NONHUMAN;
RAT;
SIGNAL TRANSDUCTION;
ANALGESICS;
ANIMALS;
BLOOD PRESSURE;
ENZYME ACTIVATION;
ENZYME INHIBITORS;
FLAVONOIDS;
HEART RATE;
IMIDAZOLES;
ISCHEMIC PRECONDITIONING, MYOCARDIAL;
MALE;
MAP KINASE SIGNALING SYSTEM;
MITOGEN-ACTIVATED PROTEIN KINASES;
MYOCARDIAL ISCHEMIA;
MYOCARDIUM;
P38 MITOGEN-ACTIVATED PROTEIN KINASES;
PYRIDINES;
QUINOLINES;
RATS;
RATS, WISTAR;
RECEPTORS, OPIOID;
|
EID: 0035074421
PISSN: 03008428
EISSN: None
Source Type: Journal
DOI: 10.1007/s003950170063 Document Type: Article |
Times cited : (102)
|
References (47)
|